09 January 2025
09 January 2025
Financing was co-led by Forbion and General Atlantic, with participants such as RA Capital Management, OrbiMed, and Lilly Asia Ventures.
The European Commission’s approval expansion follows the FDA’s same decision in July last year.
Araris will use its linker technology to generate multi-warhead ADCs for “undisclosed targets” provided by Chugai.
The collaboration includes 20 drug programmes and could yield up to $4.6bn in milestone payments for Valo.
As part of the agreement, Sanofi will provide Alloy with upfront license fees and near-term preclinical milestone payments up to $27.5m.
The company plans to create a new category of cellular medicines offering functional cures for metabolic and endocrine ailments.
This is the first approval of an HPV vaccine for males in the country.
Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
